PDCD1 and neoplasm: In an in situ tumor model constructed in BALB/C mice (Figure 7A), the application of ACBL1 in the PBRM1 wild-type group yielded results similar to those of the PBRM1 mutant group, where both promoted immune sensitization to PD1 antibodies in mice (Figure 7B and Figure 7C).